BioSpace News Archive

Yield10 Bioscience, Inc. today announced that the Company will report its second quarter 2021 financial results and provide a corporate update on Wednesday, August 11, 2021.

ABVC BioPharma, Inc. today announced the pricing of its firm commitment offering of 1,100,000 Units at an offering price of $6.25 per unit for total gross proceeds of $6.875 million.

Pulnovo Medical recently raised millions of dollars through OrbiMed, Cenova, Lilly Asia Ventures (LAV), and GaoRong Capital.

Cassava Sciences, Inc. today announced financial results for the second quarter ended June 30, 2021.

Zymeworks Inc. today announced that Janssen Biotech, Inc. (Janssen) dosed the first patient with JNJ-78278343, a bispecific antibody developed using Zymeworks’ Azymetric™ and EFECT™ therapeutic platforms.

Viveve Medical, Inc. today announced that the Canadian Intellectual Property Office (CIPO) recently issued Canadian Patent No. 3028905 for Viveve’s dual-energy technology device and method.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that New York Langone Health’s Department of Pathology will leverage Philips Genomics Workspace (formerly part of IntelliSpace Precision Medicine Platform) to integrate into their EMR (electronic medical record) environment.

Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, is pleased to announce the completion of the first successfully performed clinical case using Natus’ newly launched XactTrode™ family of platinum subdural electrodes.

Seres Therapeutics, Inc., a leading microbiome company developing a novel class of multifunctional bacterial therapeutics designed to functionally interact with host cells and tissues to treat disease, reported second quarter 2021 financial results and provided business updates.

Incyte reports 2021 second quarter financial results and provides a status update on the Company’s development portfolio.